Clinical Significance of Circulating Tumor Cells in in-operable Lung Cancer

Clinical Significance of Circulating Tumor Cells in in-operable Lung Cancer - Clinical Significance of Circulating Tumor Cells in in-operable Lung Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005037

Enrollment

Registered

2011-02-06

Start date

2011-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Diagnosed as lung cancer by histology/cytology 2.No prior treatment 3.In-operable 4. Measureable disease 5. Written informed consent

Exclusion criteria

Exclusion criteria: 1.Double cancer 2.sevior complication of major organ

Design outcomes

Primary

Measure	Time frame
To elucidate the rlationship between CTC and OS(over all survival).	—

Secondary

Measure	Time frame
To elucidate the rlationship between CTC and DFS (disease free survival), tumor response and recurrence site.	—

Countries

Japan

Contacts

Public ContactHirohisa Yoshizawa

Niigata University Medical and Dental Hospital Bioscience Medical Research Center

hy0522@med.niigata-u.ac.jp025-227-2517

Outcome results